The study of JNK/c-Jun cascade as a future target for migraine therapy [49], as well as the study of HDAC6 inhibitors [48] as potential drugs for migraine treatment, can be considered very promising, which underlines the need for more studies regarding the role of histone acetylation in migraine. The gene discussed is HDAC6; the disease is migraine disorder.